✦ LIBER ✦

Etanercept for Active Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Scribed by William J. Sandborn; Stephen B. Hanauer; Seymour Katz; Michael Safdi; Douglas G. Wolf; Richard D. Baerg; William J. Tremaine; Therese Johnson; Nancy N. Diehl; Alan R. Zinsmeister

Book ID: 119756381
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 181 KB
Volume: 121
Category: Article
ISSN: 0016-5085
DOI: 10.1053/gast.2001.28674

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease

✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des

Onercept for Moderate-to-Severe Crohn’s

Onercept for Moderate-to-Severe Crohn’s Disease: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Rutgeerts, Paul; Sandborn, William J.; Fedorak, Richard N.; Rachmilewitz, Daniel 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Ornidazole for prophylaxis of postoperat

Ornidazole for prophylaxis of postoperative Crohn’s disease recurrence: A randomized, double-blind, placebo-controlled trial

✍ Paul Rutgeerts; Gert van Assche; Séverine Vermeire; Geert D’Haens; Filip Baert; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Etanercept in Sjögren's syndrome: a pilo

Etanercept in Sjögren's syndrome: a pilot-randomized, double-blind, placebo-controlled clinical trial

✍ V Sankar; M.T Brennan; M.R Kok; R.A Leakan; J.A Smith; J Manny; B.J Baum; S.R Pi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

An engineered human antibody to TNF (CDP

An engineered human antibody to TNF (CDP571) for active crohn's disease: A randomized double-blind placebo-controlled trial

✍ William J. Sandborn; Brian G. Feagan; Stephen B. Hanauer; Daniel H. Present; Llo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

✍ J. C. MANSFIELD; M. PARKES; A. B. HAWTHORNE; A. FORBES; C. S. J. PROBERT; R.C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB